Rare diseases
Investigational molecules
Locations
Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
PolandTeclistamab drug combination versus daratumumab and lenalidomide in MRD‑positive multiple myeloma patients after stem cell transplant
PolandReduced vs Standard Dose Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Phase II MRD‑Guided Study
PolandSafety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
PolandStudy of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland
PolandLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
PolandLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
PolandSafety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia
PolandA study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.
PolandA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
PolandA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
PolandA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
